Ophthalmology News and Research

RSS
Ophthalmology is the specialized field of medicine that focuses on the health of the eye. It includes the anatomy, physiology and diseases that may affect the eye. Historically, the science of ophthalmology encompassed all aspects of visual function, both in health and in illness. Additionally, ophthalmology also includes animal eyes as ocular function and optic diseases are similar among humans and animals.
WTA report card: Many Canadian patients still face long waits for needed medical care

WTA report card: Many Canadian patients still face long waits for needed medical care

UMHHC expects to achieve 3.3% operating margin on revenues of $2.0 billion in fiscal year 2010

UMHHC expects to achieve 3.3% operating margin on revenues of $2.0 billion in fiscal year 2010

Researchers use computer-based model to study human visual intelligence

Researchers use computer-based model to study human visual intelligence

Lantis Laser to merge with Perio-Imaging

Lantis Laser to merge with Perio-Imaging

Final results from Visudyne Phase IIIb DENALI study presented at World Ophthalmology Congress

Final results from Visudyne Phase IIIb DENALI study presented at World Ophthalmology Congress

Peter and Patricia Gruber Foundation to present 2010 Neuroscience Prize to Robert H. Wurtz

Peter and Patricia Gruber Foundation to present 2010 Neuroscience Prize to Robert H. Wurtz

Equatorial Guinea advances public health services with ultramodern hospital in Bata

Equatorial Guinea advances public health services with ultramodern hospital in Bata

Synteract joins Medidata's ASPire to Win channel partner program

Synteract joins Medidata's ASPire to Win channel partner program

Better understanding of eye movements can help develop strategies for reducing crash risks: Study

Better understanding of eye movements can help develop strategies for reducing crash risks: Study

RoundTable signs agreement to acquire Ophthalmic Systems business unit

RoundTable signs agreement to acquire Ophthalmic Systems business unit

TG-MV-006 study: Microplasmin shows promise for treatment of VMA, MH

TG-MV-006 study: Microplasmin shows promise for treatment of VMA, MH

Optical coherence tomography shows promise for multiple sclerosis diagnosis

Optical coherence tomography shows promise for multiple sclerosis diagnosis

Ranibizumab improves vision in patients with visual impairment due to DME: RESTORE study

Ranibizumab improves vision in patients with visual impairment due to DME: RESTORE study

Microplasmin exhibits potential to cure 50% of patients with macular hole

Microplasmin exhibits potential to cure 50% of patients with macular hole

RTU announces phase 2 clinical trial results of UF-021 in patients with retinitis pigmentosa

RTU announces phase 2 clinical trial results of UF-021 in patients with retinitis pigmentosa

Latinos have highest rates of eye disease: New research

Latinos have highest rates of eye disease: New research

New study holds promise for patients with LCA

New study holds promise for patients with LCA

New book to prevent Age-Related Macular Degeneration

New book to prevent Age-Related Macular Degeneration

Significant progress on international development strategy for stem cell-derived human corneal tissue

Significant progress on international development strategy for stem cell-derived human corneal tissue

TAP to unveil innovative RAFT system at TERMIS Conference

TAP to unveil innovative RAFT system at TERMIS Conference

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.